NASDAQ:VXRT - US92243A2006 - Common Stock
Taking everything into account, VXRT scores 2 out of 10 in our fundamental rating. VXRT was compared to 542 industry peers in the Biotechnology industry. VXRT may be in some trouble as it scores bad on both profitability and health. VXRT is valued quite expensive, but it does show an excellent growth.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -36.66% | ||
ROE | -127.41% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.01 | ||
Debt/FCF | N/A | ||
Altman-Z | -5.12 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 0.64 | ||
Quick Ratio | 0.64 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
0.32
-0.11 (-25.06%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 1.54 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 1.6 | ||
P/tB | 1.94 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -36.66% | ||
ROE | -127.41% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | N/A | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.01 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 6.2% | ||
Cap/Sales | 1.17% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 0.64 | ||
Quick Ratio | 0.64 | ||
Altman-Z | -5.12 |